Amy Jo Sterling

Array ( [id] => 7033665 [patent_doc_number] => 20050032175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'High affinity fusion proteins and therapeutic and diagnostic methods for use' [patent_app_type] => utility [patent_app_number] => 10/879994 [patent_app_country] => US [patent_app_date] => 2004-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9446 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032175.pdf [firstpage_image] =>[orig_patent_app_number] => 10879994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7275666 [patent_doc_number] => 20040235117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins' [patent_app_type] => new [patent_app_number] => 10/871776 [patent_app_country] => US [patent_app_date] => 2004-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 18453 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235117.pdf [firstpage_image] =>[orig_patent_app_number] => 10871776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4964972 [patent_doc_number] => 20080107792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Use of Plants with Increased Levels of Flavonol Glycosides in Reducing Hypertension' [patent_app_type] => utility [patent_app_number] => 10/566806 [patent_app_country] => US [patent_app_date] => 2004-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6812 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20080107792.pdf [firstpage_image] =>[orig_patent_app_number] => 10566806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7275658 [patent_doc_number] => 20040235109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/854947 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 65358 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235109.pdf [firstpage_image] =>[orig_patent_app_number] => 10854947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7461544 [patent_doc_number] => 20040197870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Human tumor necrosis factor receptor TR9' [patent_app_type] => new [patent_app_number] => 10/834966 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 87634 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20040197870.pdf [firstpage_image] =>[orig_patent_app_number] => 10834966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7409528 [patent_doc_number] => 20040176279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Flint glycoforms' [patent_app_type] => new [patent_app_number] => 10/466786 [patent_app_country] => US [patent_app_date] => 2004-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9070 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176279.pdf [firstpage_image] =>[orig_patent_app_number] => 10466786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7427678 [patent_doc_number] => 20040209265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins and uses thereof' [patent_app_type] => new [patent_app_number] => 10/472442 [patent_app_country] => US [patent_app_date] => 2004-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 19965 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209265.pdf [firstpage_image] =>[orig_patent_app_number] => 10472442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 928412 [patent_doc_number] => 07314722 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-01 [patent_title] => 'Cytostatin II antibodies and methods' [patent_app_type] => utility [patent_app_number] => 10/822787 [patent_app_country] => US [patent_app_date] => 2004-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18015 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/314/07314722.pdf [firstpage_image] =>[orig_patent_app_number] => 10822787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 803421 [patent_doc_number] => 07423125 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-09 [patent_title] => 'Antibodies to VEGF-C' [patent_app_type] => utility [patent_app_number] => 10/792461 [patent_app_country] => US [patent_app_date] => 2004-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 20 [patent_no_of_words] => 39798 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/423/07423125.pdf [firstpage_image] =>[orig_patent_app_number] => 10792461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 859839 [patent_doc_number] => 07371388 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-05-13 [patent_title] => 'Treatment of Sjogren\'s syndrome by administration of TR18 polypeptides' [patent_app_type] => utility [patent_app_number] => 10/786176 [patent_app_country] => US [patent_app_date] => 2004-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 111134 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/371/07371388.pdf [firstpage_image] =>[orig_patent_app_number] => 10786176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9983912 [patent_doc_number] => 09029629 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-12 [patent_title] => 'Altered FAD2 and FAD3 genes in Brassica and the molecular marker-assisted detection thereof' [patent_app_type] => utility [patent_app_number] => 10/545100 [patent_app_country] => US [patent_app_date] => 2004-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 8 [patent_no_of_words] => 8692 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10545100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 923168 [patent_doc_number] => 07319140 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-15 [patent_title] => 'Binding compounds to DAP12 proteins' [patent_app_type] => utility [patent_app_number] => 10/775640 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31317 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/319/07319140.pdf [firstpage_image] =>[orig_patent_app_number] => 10775640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7419599 [patent_doc_number] => 20040177391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Mammalian cell membrane proteins;related reagents' [patent_app_type] => new [patent_app_number] => 10/775423 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31262 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20040177391.pdf [firstpage_image] =>[orig_patent_app_number] => 10775423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7308855 [patent_doc_number] => 20040142420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Novel molecules of the TANGO-93-related protein family and uses thereof' [patent_app_type] => new [patent_app_number] => 10/734985 [patent_app_country] => US [patent_app_date] => 2003-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 30526 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142420.pdf [firstpage_image] =>[orig_patent_app_number] => 10734985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 492107 [patent_doc_number] => 07211246 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-01 [patent_title] => 'Compositions comprising oestrone-3-0-sulphamate and trail (TNF-related apoptosis inducing ligand)' [patent_app_type] => utility [patent_app_number] => 10/728383 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12027 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/211/07211246.pdf [firstpage_image] =>[orig_patent_app_number] => 10728383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7202887 [patent_doc_number] => 20040086971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Adipocyte complement related protein ZACRP3X2' [patent_app_type] => new [patent_app_number] => 10/719205 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41302 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086971.pdf [firstpage_image] =>[orig_patent_app_number] => 10719205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7328164 [patent_doc_number] => 20040253605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other uses' [patent_app_type] => new [patent_app_number] => 10/718332 [patent_app_country] => US [patent_app_date] => 2003-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 31530 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20040253605.pdf [firstpage_image] =>[orig_patent_app_number] => 10718332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7202862 [patent_doc_number] => 20040086967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Human criptin growth factor' [patent_app_type] => new [patent_app_number] => 10/665602 [patent_app_country] => US [patent_app_date] => 2003-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11619 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086967.pdf [firstpage_image] =>[orig_patent_app_number] => 10665602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 486693 [patent_doc_number] => 07217790 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-15 [patent_title] => 'UMLR polypeptides' [patent_app_type] => utility [patent_app_number] => 10/660968 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41400 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/217/07217790.pdf [firstpage_image] =>[orig_patent_app_number] => 10660968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7166749 [patent_doc_number] => 20040077051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'LSR receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications' [patent_app_type] => new [patent_app_number] => 10/650507 [patent_app_country] => US [patent_app_date] => 2003-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 38525 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077051.pdf [firstpage_image] =>[orig_patent_app_number] => 10650507 [rel_patent_id] =>[rel_patent_doc_number] =>)